Logo-aim
Arch Iran Med. 2025;28(1): 29-39. doi: 10.34172/aim.33366
PMID: 40001327        PMCID: PMC11862391

Original Article

Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis?

Mehmet Sait Ozsoy 1 ORCID, Cem Ilgin Erol 2 ORCID, Muhammet Ali Aydemir 1 * ORCID, Hakan Baysal 1 ORCID, Fatih Buyuker 1 ORCID, Hatice Seneldir 3 ORCID, Ozgur Ekinci 1 ORCID, Tunc Eren 1 ORCID, Orhan Alimoglu 1 ORCID

Cited by CrossRef:

1- Ergenç M, Yazıcı H, Yılmaz F, Akmercan A, Bulut A, Karpuz Ş, Coşkun M, Bozkurtlar E, Uprak T, Atıcı A, Uğurlu M, Cingi A, Günal Ö, Yeğen C. Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control. 2026;33 [Crossref]
2- Moeinipour Y, Abedi F, Sadeghi M, Moeinipour A, Shourab A, Ghods K, Faridnia B, Mohammadpour A. The Association Between Proton Pump Inhibitor Use and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review. J Gastrointest Canc. 2025;56(1) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.